Target Corporation enters its Q1 2026 earnings — scheduled for May 20 — with a stock down 5.4% on the week, a cluster of upward analyst revisions, and options traders quietly building more defensive positioning than the past year's average. The tension is real: the Street is raising targets into the print, but the market has sold the name ahead of it.
The most notable development this week is an unusually coordinated pattern of analyst upgrades to price targets. Five separate firms have raised their targets in the past week alone — Wells Fargo lifted to $140 (from $135, maintaining Overweight), Barclays nudged to $115 (from $108, keeping its Underweight), Truist moved to $123 (from $121, Hold), and Citi earlier raised to $133. The direction of travel is broadly positive, but the ratings themselves tell a more divided story: bulls at Wells Fargo and Guggenheim ($140 target) sit alongside notable holdouts at Barclays, who still carry a below-consensus Underweight. The consensus target of $126.50 sits modestly above Tuesday's close of $121.80 — a thin 3.9% gap that leaves little room for disappointment. The bull case rests on Target's 8.1x 2026 EBITDA multiple and private-label momentum; bears point to structural grocery weakness and the difficulty of competing with WMT and Costco on traffic.
Options positioning has turned more cautious than usual in the run-up to the print. The put/call ratio has climbed to 0.86 — roughly 1.45 standard deviations above its 20-day average of 0.80 — putting it near the upper end of a year-long range (52-week high: 0.98). That's not panic, but it reflects a market that has quietly stepped up demand for downside protection. The move has been steady over the past three weeks rather than a single spike, suggesting the caution is deliberate positioning ahead of earnings rather than reactive hedging.
Short interest tells a less alarming story. At 3.46% of free float — down roughly 14% over the past month — shorts have been unwinding steadily since mid-April, when positions peaked near 4.2% of float. Borrow costs are nominal at 0.38% and availability in the lending pool remains extremely loose. The ORTEX short score of 35 is squarely in the middle of the range, implying no unusual conviction from the short side. This is not a stock the bears are crowding into ahead of the number.
The mid-April short-covering is worth contextualising against earnings history. When Target last reported in early March, the stock jumped 6.1% the next day and held most of the gain through the following week — a notably cleaner reaction than the November 2025 print, which delivered a 5.5% down-day. Two events is a thin sample, but the March reaction (positive surprise, sustained move) coincided with a period when short interest was materially higher. The current setup has fewer short sellers exposed, which cuts both ways: there is less fuel for a squeeze if results disappoint.
Factor scores add nuance to the valuation picture. Target's dividend score is in the 98th percentile — a reminder that the stock has a strong income profile even at current prices — while EPS surprise ranks in the 75th percentile, supporting the bull case that Target consistently delivers above expectations. EV/EBITDA has drifted up slightly over the past 30 days to around 8.3x, consistent with a very modest re-rating as the stock recovered from its April lows. Among close retail peers, WMT ended the week broadly flat while DLTR fell nearly 5% — underscoring that discount retail broadly sold off this week, with Target slightly underperforming its larger-cap cousin.
The May 20 print is therefore less about whether Target can grow and more about whether management's guidance on tariff-exposed categories — apparel, home, electronics — gives the Street enough confidence to push the stock through that thin analyst-target ceiling.
See the live data behind this article on ORTEX.
Open TGT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
